MYR Pharma is a German clinical stage biotechnology company focused on drugs for the treatment of chronic hepatitis B and D virus infections. The company`s lead compound is currently progressing into Phase 3 studies in the indication chronic HDV infection.
Contributions
Contributors
Contributions
Nice Insight is the market research division of That's Nice LLC, the leading marketing agency serving life sciences.
